Herpes virus simplex infection: Host-virus interaction;Infection par le virus herpes simplex: Interaction virus-hôte

Pathologie Biologie

Volumn 50, Issue 7, 2002, Pages 414-418

  Rozenberg, Flore ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Gene therapy; Herpes simplex virus; Latency; Neurovirulence; Receptors

Indexed keywords

VIRUS RECEPTOR;

ANIMAL MODEL; ARTICLE; GENE THERAPY; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; LATENT VIRUS INFECTION; NEUROPATHOLOGY; NONHUMAN; VIRUS CELL INTERACTION; VIRUS REACTIVATION; VIRUS VIRULENCE;

ENCEPHALITIS, HERPES SIMPLEX; GENETIC VECTORS; HERPES SIMPLEX; HUMANS; MEMBRANE FUSION; NERVOUS SYSTEM; NEURONS; RECEPTORS, VIRUS; RETINITIS; SIMPLEXVIRUS; VIRAL PROTEINS; VIRULENCE; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0036694238     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00326-7     Document Type: Article

References (21)

1. Campadelli-Fiume G, Cocchi F, Menotti L, Lopez M. The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev. Med. Virol. 2000;10(5): 305-19.
2. Cocchi F, Menotti L, Mirandola P, et al. The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus type 1 and 2 in human cells. J. Virol. 1998;72:9992-10002.
3. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998;280: 1618-20.
4. Montgomery RJ, Warner MS, Lum BJ, Spear PG. Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996;87:422-36.
5. Roizman B, Sears AE. Herpes simplex viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al., editors. Virology, third éd., vol. 72. Philadelphie: Raven publishers; 1996. p. 2231-95.
6. Roizman B. The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc. Natl. Acad. Sci. 1996;93:11307-12.
7. Kristensson K, Vahlne A, Persson LA, Lycke E. Neural spread of herpes simplex virus types 1 & 2 in mice after corneal or subcutaneous (foot-pad) inoculation. J. Neurol. Sci. 1978;35:331-40.
8. Millhouse S, Wigdahl B. Molecular circuitry regulating HSV-1 latency in neurons. J. Neurovirol. 2000;6:6-24.
9. Leib DA, Bogard CL, Kosz-Vnenchak M, et al. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 1989;63:2893-900.
10. Margolis TP, Dawson CR, LaVail JH. Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistocheminal analysis of cell populations. Invest. Ophtalmol. Vis. Sci. 1992;33:259-67.
11. Margolis TP, Sedarati F, Dobson AT, Feldman LT, Stevens JG. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 1992;189:150-60.
12. Wilcox CL, Johnson EM. Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro. J. Virol. 1988;62:393-9.
13. Kristie TM, Vogel JL, Sears AE. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl. Acad. Sci. 1999;96:1229-33.
14. Ugolini G, Kuypers H, Strick PL. Transneuronal transfer of herpes virus from peripheral nerves to cortex and brainstem. Science 1989;243:89-91.
15. Mitchell BR, Stevens JG. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controled by the immune response. Virology 1996;156:246-55.
16. Chou J, Kerner E, Whitley RJ, Roizman B. Mapping of herpes simplex virus 1 neurovirulence to υ 34,5, a gene non essential for growth in culture. Science 1990;250:1262-6.
17. Chou J, Roizman B. The υ 34,5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shut-off of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. 1992;89:3266-70.
18. Chou J, Roizman B. Herpes simplex virus 1 υ 34,5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc. Natl. Acad. Sci. 1994;91:5247-51.
19. Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW. Specific phenotypic restoration of an attenuated virus by knock-out of a host resistance gene. Proc. Natl. Acad. Sci. 2000;97:6097-101.
20. Jacobs A, Breakefield XO, Fraefel C. HSV-1 based vectors for gene therapy of neurological diseases and brain tumors. part II. Vector systems and applications. Neoplasia 1999;1:402-16.
21. Markert JM, Medlock MD, Rabkin SD, et al. Conditionnally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. Gene Therapy 2000;10:867-74.